Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,228
Total Claims
$2.8M
Drug Cost
696
Beneficiaries
$4,090
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 9,082 Pulmonary Disease providers
-20%
Cost per patient vs peers
$4,090 vs $5,138 avg
-58%
Brand preference vs peers
25.8% vs 61.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.7%
Opioid Rate
77
Opioid Claims
$1,908
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,882 claims · $2.7M
Generic: 8,300 claims · $170K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Nintedanib Esylate | 62 | $865K |
| Sodium,calcium,mag,pot Oxybate | 13 | $251K |
| Budesonide/Formoterol Fumarate | 436 | $221K |
| Fluticasone/Umeclidin/Vilanter | 268 | $205K |
| Tezepelumab-Ekko | 25 | $103K |
| Dupilumab | 22 | $92K |
| Budesonide/Glycopyr/Formoterol | 91 | $73K |
| Tiotropium Bromide | 88 | $63K |
| Fluticasone/Vilanterol | 133 | $61K |
| Fluticasone Propion/Salmeterol | 107 | $58K |
| Tiotropium Br/Olodaterol Hcl | 88 | $49K |
| Umeclidinium Brm/Vilanterol Tr | 95 | $48K |
| Apixaban | 90 | $44K |
| Umeclidinium Bromide | 85 | $36K |
| Tiotropium Bromide | 33 | $34K |
Prescribing Profile
Patient Profile
74
Avg Age
61%
Female
1.68
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About